Navigation Links
Combining CT, FDG-PET provides more accurate treatments for head and neck cancer patients
Date:4/29/2011

Combining computerized tomography (CT) with fluorodeoxyglucose positron emission tomography (FDG-PET) images results in significantly more defined tumor outlines and potentially different treatment options in head and neck cancer patients compared to using CT alone, according to research presented today, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. This symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).

CT is the standard method for determining tumor delineation before deciding head and neck cancer treatmenttypically intensity modulated radiation therapy. However, FDG-PET is an imaging method that uses a radioactive product combined with sugar and can produce better defined outlines of the tumor.

Researchers sought to determine the significance of combining CT and FDG-PET when determining tumor delineation and treatment for head and neck cancer patients.

In this trial, 327 patients were treated with IMRT for head and neck cancer. Based on the combined approach of the CT-scan and FDG-PET, the researchers noticed a change in the delineation of the tumor in one out of three patients, resulting in 10 percent of patients' treatment being changed and 33 percent of patients having their treatment adjusted.

In 17 percent of the patients, the primary tumor was not visible on the CT-scan alone, mostly due to dental inlays.

"We expected there to be an improved delineation of the tumor," Homan Dehnad, MD, a study author and radiation oncologist at Utrecht University Medical Center in Utrecht, Netherlands, said. "However, we never expected it to have such an influence on the treatment options for patients. Each dedicated institute dealing with head and neck cancer should be equipped with multi-imaged facilities."


'/>"/>

Contact: Beth Bukata
bethb@astro.org
American Society for Radiation Oncology
Source:Eurekalert

Page: 1

Related medicine news :

1. Combining MEK and PI3K inhibitors appears encouraging in a safety study with early signs of anti-tumor activity
2. Combining 2 peptide inhibitors might block tumor growth
3. Visual prostheses: Symposium to explore combining functional endpoints
4. Study provides molecular rationale for combining targeted agents to treat breast cancer
5. Combining radiation therapy, chemotherapy safely treats head and neck cancer patients
6. Combining medication and psychosocial treatments may benefit patients with early-stage schizophrenia
7. Combining resistance and endurance training best for heart health
8. FDG-PET/CT plays a definite role in detecting colorectal cancer recurrences
9. Teachers-based intervention provides stress resistance in war-exposed children
10. Discovery of 2 new genes provides hope for stemming Staph infections
11. Study provides first link between 2 major Parkinsons genes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... June 26, 2017 , ... A new and improved Orgasm-Shot ... look and feel about themselves and their sexual encounters. A unique medical practice ... leakage head on with a ground breaking medical technique aimed to give women ...
(Date:6/26/2017)... ... 2017 , ... KICKICO , a protocol built on Ethereum for more ... catastrophic issues within funding campaigns. KICKICO developers are testing the platform, which will launch ... raising of funds through the power of many - has been around for about ...
(Date:6/25/2017)... ... ... lyric music video in Final Cut Pro X with ProLyric from Pixel Film Studios. Users ... to any song. ProLyric flies in the text for each section and it hovers around ... for optimal control. ProLyric makes editing any music video or text-based production easier than ever. ...
(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the ... New Orleans. This is a new, greatly improved version of the Doctor Referral teaming ... requests by Fred Trotter and subsequently called the the “Doctor Referral Dataset” as released ...
(Date:6/24/2017)... ... June 24, 2017 , ... ... testing for medications in select Florida and Texas doctors' offices and clinics. This ... new application of genetic testing recognizes the role genes play in determining an ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)...  NxStage Medical, Inc. (Nasdaq:  NXTM), a leading medical technology company ... demonstrating positive biochemical outcomes related to more frequent hemodialysis ... will be presented at the ERA-EDTA Congress being held ... . The research was conducted by ... Europe (KIHDNEy) Cohort team ...
(Date:5/30/2017)... May 30, 2017 DarioHealth Corp. (NASDAQ: DRIO), a leading ... today announced that it will be presenting at the 7th annual ... PT. Erez Raphael , CEO, of DarioHealth will be giving ... be held on June 6th & 7th, 2017 at the Luxe ... small / micro-cap space. About ...
(Date:5/30/2017)... Therapix Biosciences Ltd. (Nasdaq: TRPX), a ... development of cannabinoid-based drugs, today announced that the ... three upcoming scientific and investor conferences in June: ... ... Wednesday, June 7 ...
Breaking Medicine Technology: